These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11298610)

  • 1. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura.
    Newman GC; Novoa MV; Fodero EM; Lesser ML; Woloski BM; Bussel JB
    Br J Haematol; 2001 Mar; 112(4):1076-8. PubMed ID: 11298610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.
    Scaradavou A; Woo B; Woloski BM; Cunningham-Rundles S; Ettinger LJ; Aledort LM; Bussel JB
    Blood; 1997 Apr; 89(8):2689-700. PubMed ID: 9108386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
    Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB
    Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG.
    Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J
    Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
    Son DW; Jeon IS; Yang SW; Cho SH
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous anti-D immunoglobulin in the treatment of resistant immune thrombocytopenic purpura in pregnancy.
    Sieunarine K; Shapiro S; Al Obaidi M; Girling J
    BJOG; 2007 Apr; 114(4):505-7. PubMed ID: 17309547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.
    Bussel JB; Graziano JN; Kimberly RP; Pahwa S; Aledort LM
    Blood; 1991 May; 77(9):1884-93. PubMed ID: 1850307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D).
    Becker T; Küenzlen E; Salama A; Mertens R; Kiefel V; Weiss H; Lampert F; Gaedicke G; Mueller-Eckhardt C
    Eur J Pediatr; 1986 Aug; 145(3):166-9. PubMed ID: 3021462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
    Blanchette VS; Luke B; Andrew M; Sommerville-Nielsen S; Barnard D; de Veber B; Gent M
    J Pediatr; 1993 Dec; 123(6):989-95. PubMed ID: 8229536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.
    Aledort LM; Salama A; Kovaleva L; Robak T; Newland AC; Nugent DJ; Brenner B; Zenker O;
    Hematology; 2007 Aug; 12(4):289-95. PubMed ID: 17654054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura.
    Sandoval C; Visintainer P; Ozkaynak MF; Tugal O; Jayabose S
    Pediatr Blood Cancer; 2004 Jan; 42(1):109-12. PubMed ID: 14752803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).
    Salama A; Kiefel V; Amberg R; Mueller-Eckhardt C
    Blut; 1984 Jul; 49(1):29-35. PubMed ID: 6430368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.